Iron supplementation moderates but does not cure the Belgrade anemia

Area of Science:

• Genetics
• Hematology
• Nutritional Science

Background:

• Belgrade rats exhibit an autosomal recessive microcytic, hypochromic anemia (gene symbol b).
• Affected rats display iron deficiency in erythrocytes and tissues, despite elevated total iron-binding capacity (TIBC) and transferrin saturation.
• Previous iron injections improved erythrocyte counts but not morphology.

Purpose of the Study:

• To investigate iron supplementation strategies for improving the husbandry of Belgrade rats (b/b).
• To elucidate the underlying defect and its tissue distribution in Belgrade rats.
• To assess the impact of dietary and parenteral iron on iron status and health parameters.

Main Methods:

• Administration of weekly intramuscular iron-dextran injections.
• Evaluation of various diets focusing on iron bioavailability.
• Measurement of tissue iron levels, serum iron, and TIBC.
• Assessment of hematological parameters, weight, survival, and reproductive success.

Main Results:

• Intramuscular iron-dextran improved anemia but not red blood cell morphology.
• Dietary ferrous iron supplementation significantly improved overall health, including weight, survival, hematology, and reproduction.
• Dietary iron partially alleviated tissue iron deficiency and decreased elevated TIBC, while injections led to higher tissue iron accumulation.
• Untreated b/b rats showed elevated serum iron and TIBC, indicative of an iron regulation or uptake issue.

Conclusions:

• Iron supplements, particularly dietary ferrous iron, can significantly improve the health and husbandry of Belgrade rats.
• The underlying genetic defect in Belgrade rats does not appear to be corrected by iron supplementation.
• Findings suggest a potential defect in gastrointestinal iron absorption in Belgrade rats.